GH
KERX

GAM Holding’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

GAM Holding’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-44,000
Closed -$623K – 1146
2014
Q4 		$623K Hold
44,000
– – 0.01% 816
2014
Q3 		$605K Hold
44,000
– – 0.01% 804
2014
Q2 		$677K Hold
44,000
– – 0.01% 778
2014
Q1 		$750K Buy
+44,000
New +$664K 0.01% 741

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GAM Holding's KERX Position: Q1 2015 in Review

GAM Holding sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2015, closing a stake of 44,000 shares — an estimated $623K sold.

GAM Holding first reported a position in KERX in Q1 2014 and held it in 4 quarters. The position peaked at $750K in Q1 2014. 157 funds tracked by Wall St. Rank hold KERX as of Q1 2015.

  • GAM Holding reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • GAM Holding sold 44,000 Keryx Biopharmaceuticals Inc shares in Q1 2015, an estimated $623K.
  • GAM Holding first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 4 quarters.
  • GAM Holding's Keryx Biopharmaceuticals Inc position peaked at $750K in Q1 2014.
  • 157 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2015.

Based on GAM Holding's 13F filing for Q1 2015, filed 12 May 2015.